Prescription Drug Information: Abacavir (Page 6 of 6)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 20 mg/mL (240 mL Bottle Label)

NDC 65862-089-24
Rx only
Abacavir
Oral Solution USP
20 mg/mL
AUROBINDO 240 mL

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 20 mg/mL (240 mL Bottle Label)
(click image for full-size original)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 20 mg/mL (240 mL Carton Label)

NDC 65862-089-24
Abacavir
Oral Solution USP
20 mg/mL
Notice to Authorized Dispenser:
Each time ABACAVIR ORAL
SOLUTION USP is dispensed,
give the patient an attached
Medication Guide and Warning
Card from the carton.
Rx only 240 mL
AUROBINDO

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 20 mg/mL (240 mL Carton Label)
(click image for full-size original)

ABACAVIR abacavir sulfate solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65862-089
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ABACAVIR SULFATE (ABACAVIR) ABACAVIR 20 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
STRAWBERRY
BANANA
ANHYDROUS CITRIC ACID
METHYLPARABEN
PROPYLPARABEN
PROPYLENE GLYCOL
SACCHARIN SODIUM
TRISODIUM CITRATE DIHYDRATE
SORBITOL
WATER
Product Characteristics
Color YELLOW Score
Shape Size
Flavor BANANA, STRAWBERRY Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:65862-089-24 1 BOTTLE in 1 CARTON contains a BOTTLE
1 240 mL in 1 BOTTLE This package is contained within the CARTON (65862-089-24)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077950 03/14/2018
Labeler — Aurobindo Pharma Limited (650082092)
Establishment
Name Address ID/FEI Operations
Aurobindo Pharma Limited 918917642 ANALYSIS (65862-089), MANUFACTURE (65862-089)

Revised: 09/2019 Aurobindo Pharma Limited

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Medication Sections

Medication Information by RSS

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2020. All Rights Reserved.